Descovy
-
FDA approves Gilead Sciences Inc’s Descovy to reduce the risk of HIV infection
Oct 4, 2019The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc’s Descovy to reduce the risk of sexually acquired HIV infection in men and transgender women who have sex with men. The approval does not include...
